NYSE - Delayed Quote • USD
Danaher Corporation (DHR)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:35 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 24 | 24 |
| Avg. Estimate | 1.63 | 1.81 | 7.63 | 8.72 |
| Low Estimate | 1.55 | 1.63 | 7.45 | 8.35 |
| High Estimate | 1.81 | 1.94 | 7.99 | 9.37 |
| Year Ago EPS | 2.05 | 1.84 | 7.58 | 7.63 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 24 | 24 |
| Avg. Estimate | 5.66B | 5.83B | 23.98B | 26.02B |
| Low Estimate | 5.54B | 5.6B | 23.49B | 25.2B |
| High Estimate | 5.81B | 5.99B | 24.49B | 27.13B |
| Year Ago Sales | 7.11B | -- | 23.89B | 23.98B |
| Sales Growth (year/est) | -20.30% | -- | 0.40% | 8.50% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 2.01 | 1.7 | 1.91 | 1.71 |
| EPS Actual | 2.05 | 1.84 | 2.09 | 1.92 |
| Difference | 0.04 | 0.14 | 0.18 | 0.21 |
| Surprise % | 2.00% | 8.20% | 9.40% | 12.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.63 | 1.81 | 7.63 | 8.72 |
| 7 Days Ago | 1.68 | 1.9 | 7.62 | 8.68 |
| 30 Days Ago | 1.68 | 1.91 | 7.62 | 8.66 |
| 60 Days Ago | 1.55 | 1.76 | 7.03 | 7.98 |
| 90 Days Ago | 1.85 | 1.89 | 7.78 | 8.75 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 3 | 6 |
| Up Last 30 Days | 1 | -- | 3 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 9 | 9 | 7 | 5 |
Growth Estimates
| CURRENCY IN USD | DHR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -20.50% | -- | -- | 1.50% |
| Next Qtr. | -1.60% | -- | -- | 11.40% |
| Current Year | 0.70% | -- | -- | 5.20% |
| Next Year | 14.30% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 1.90% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 19.15% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 4/24/2024 |
| Maintains | TD Cowen: Buy to Buy | 4/24/2024 |
| Maintains | B of A Securities: Neutral to Neutral | 4/24/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/24/2024 |
| Maintains | Baird: Outperform to Outperform | 4/24/2024 |
| Upgrade | HSBC: Hold to Buy | 4/17/2024 |
Related Tickers
TMO Thermo Fisher Scientific Inc.
577.39
+0.49%
MEDP Medpace Holdings, Inc.
397.56
-2.36%
DGX Quest Diagnostics Incorporated
137.55
+0.62%
ILMN Illumina, Inc.
122.87
-1.28%
IDXX IDEXX Laboratories, Inc.
494.26
+0.09%
ME 23andMe Holding Co.
0.4671
-5.39%
A Agilent Technologies, Inc.
137.49
-1.23%
WAT Waters Corporation
310.25
-0.97%
GH Guardant Health, Inc.
18.10
+4.38%
EXAS Exact Sciences Corporation
63.24
-0.46%